On Aug. 24, 2018, Emory University’s Alzheimer’s Disease Research Center was renamed the Goizueta Alzheimer’s Disease Research Center, in honor of the Goizueta Foundation’s support for disease research.

In May 2018, The Goizueta Foundation made a $25 million grant to the ADRC dedicated to the development of a Clinical Trials Unit and to support the Neuroinflammation Discovery Unit.

• In the Clinical Trials Unit, investigators will expand the testing of new drug treatments, including industry-sponsored trials.
• In the Neuroinflammation Discovery Unit, Emory investigators will pursue research focused on new approaches to combat neuro-inflammation and related mechanisms that contribute to neurodegeneration and disease progression.

The Goizueta Foundation made an initial investment of $25 million in the ADRC in 2014, and a subsequent $3.9 million supplemental gift, to launch and support the Emory Healthy Aging Study and the Healthy Brain Study — both of which are ongoing and still enrolling participants.

The Goizueta Alzheimer’s Disease Research Center is part of the Emory Brain Health Center and is one of 32 Alzheimer’s disease research centers nationally, and one of only a few in the Southeast, that are supported by the National Institutes of Health. This network of Alzheimer’s disease research centers is working collaboratively to find a treatment for the disease by 2025.